Bone Biologics Corp (BBLG)
1.47
-0.35
(-19.23%)
USD |
NASDAQ |
May 21, 13:07
Bone Biologics Total Assets (Quarterly): 3.840M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 3.840M |
December 31, 2023 | 3.738M |
September 30, 2023 | 4.976M |
June 30, 2023 | 7.623M |
March 31, 2023 | 6.784M |
December 31, 2022 | 8.495M |
September 30, 2022 | 5.201M |
June 30, 2022 | 5.659M |
March 31, 2022 | 6.094M |
December 31, 2021 | 6.675M |
September 30, 2021 | 0.0524M |
June 30, 2021 | 0.0044M |
March 31, 2021 | 0.0712M |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.0025M |
June 30, 2020 | 0.0014M |
March 31, 2020 | 0.007M |
Date | Value |
---|---|
December 31, 2019 | 0.0308M |
September 30, 2019 | 0.2493M |
June 30, 2019 | 0.2664M |
March 31, 2019 | 0.8141M |
December 31, 2018 | 1.041M |
September 30, 2018 | 2.350M |
June 30, 2018 | 0.3777M |
March 31, 2018 | 0.4705M |
December 31, 2017 | 0.7957M |
September 30, 2017 | 1.940M |
June 30, 2017 | 1.140M |
March 31, 2017 | 1.968M |
December 31, 2016 | 0.7011M |
September 30, 2016 | 1.072M |
June 30, 2016 | 2.635M |
March 31, 2016 | 4.622M |
December 31, 2015 | 1.547M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2020
8.495M
Maximum
Dec 2022
2.988M
Average
2.002M
Median
Total Assets (Quarterly) Benchmarks
ThermoGenesis Holdings Inc | 11.23M |
BioVie Inc | 31.77M |
Krystal Biotech Inc | 853.30M |
Adial Pharmaceuticals Inc | 6.684M |
NovaBay Pharmaceuticals Inc | 5.357M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 0.1646M |
Shareholders Equity (Quarterly) | 3.675M |